Cellectis S.A.
CLLS
$1.41
-$0.03-2.08%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -421.25% | 114.17% | -31.88% | -115.85% | 118.76% |
| Total Depreciation and Amortization | 7.92% | -0.82% | 5.69% | 6.99% | 2.54% |
| Total Amortization of Deferred Charges | -- | 998.55% | -- | -- | -- |
| Total Other Non-Cash Items | 129.45% | -198.68% | 437.35% | 204.91% | -423.39% |
| Change in Net Operating Assets | -26.18% | -91.09% | -607.93% | 10,475.34% | 13.90% |
| Cash from Operations | 26.40% | -100.12% | 65.90% | 374.01% | 17.69% |
| Capital Expenditure | -81.19% | -99.28% | -147.45% | -284.44% | -2.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 351.94% | -20.45% | 164,971.43% | -6,842.75% | -513.77% |
| Cash from Investing | 305.90% | -22.04% | 7,544.33% | -5,852.40% | -991.74% |
| Total Debt Issued | -- | 395.61% | -98.10% | -100.20% | -- |
| Total Debt Repaid | 4.60% | 7.10% | -0.47% | -1.16% | -2.28% |
| Issuance of Common Stock | -- | -99.56% | -- | 44,539.78% | -- |
| Repurchase of Common Stock | -- | -- | 85.24% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 33.19% | 80.34% | -102.61% | -131.17% | 77.69% |
| Cash from Financing | -134.38% | -92.97% | -349.88% | 296.18% | -39.86% |
| Foreign Exchange rate Adjustments | 628.84% | -220.46% | -69.49% | 1,164.12% | -139.91% |
| Miscellaneous Cash Flow Adjustments | -- | 200.00% | 0.00% | 0.00% | -- |
| Net Change in Cash | -13.67% | -122.84% | 159.00% | 2,303.80% | -79.64% |